OLMA - SEC Form 4 insider transactions

SEC Form 4 filed by Director Raman Prakash

CHIEF LEGAL OFFICER Mitchell Shawnte exercised 40,000 shares at a strike of $4.37, sold $945,750 worth of shares (39,767 units at $23.78) and sold $5,753 worth of Comon Stock (233 units at $24.69) (SEC Form 4)

VP of Finance and Controller Austin Sasha Lu was granted 11,700 shares, increasing direct ownership by 261% to 16,188 units (SEC Form 4)

SEC Form 4 filed by CHIEF MEDICAL OFFICER Zojwalla Naseem

SEC Form 4 filed by PRESIDENT AND CEO Bohen Sean

SEC Form 4 filed by CH. DISCOV. & NON-CLIN DEV OFF Myles David C.

SEC Form 4 filed by CHIEF LEGAL OFFICER Mitchell Shawnte

Director Harmon Cyrus sold $268,800 worth of shares (10,000 units at $26.88), decreasing direct ownership by 1% to 727,770 units (SEC Form 4)

Director Harmon Cyrus sold $101,600 worth of shares (3,489 units at $29.12), decreasing direct ownership by 0.47% to 737,770 units (SEC Form 4)

CH. OPERATING & FINANCIAL OFF. Kovacs Shane William Charles sold $2,980,054 worth of shares (103,822 units at $28.70), decreasing direct ownership by 43% to 139,727 units (SEC Form 4)

CH. DISCOV. & NON-CLIN DEV OFF Myles David C. exercised 100,000 shares at a strike of $4.87 and sold $3,107,229 worth of shares (110,000 units at $28.25) (SEC Form 4)

President and CEO Bohen Sean gifted 8,500 shares, decreasing direct ownership by 3% to 237,650 units (SEC Form 4)

Director Harmon Cyrus sold $82,195 worth of shares (2,881 units at $28.53), decreasing direct ownership by 0.39% to 741,259 units (SEC Form 4)

Director Clark Ian T sold $7,873,109 worth of shares (264,800 units at $29.73) and exercised 264,800 shares at a strike of $4.61 (SEC Form 4)

CH. DISCOV. & NON-CLIN DEV OFF Myles David C. sold $1,553,544 worth of shares (51,000 units at $30.46) and gifted 9,000 shares, decreasing direct ownership by 10% to 542,881 units (SEC Form 4)

Chief Medical Officer Zojwalla Naseem exercised 140,000 shares at a strike of $11.89 and sold $7,530,148 worth of shares (269,509 units at $27.94), decreasing direct ownership by 97% to 4,488 units (SEC Form 4)

CH. OPERATING & FINANCIAL OFF. Kovacs Shane William Charles gifted 75,000 shares, decreasing direct ownership by 24% to 243,549 units (SEC Form 4)

CH. OPERATING & FINANCIAL OFF. Kovacs Shane William Charles gifted 225,000 shares, decreasing direct ownership by 41% to 318,549 units (SEC Form 4)

Director Rappaport Andrew exercised 35,868 shares at a strike of $0.39 and gifted 35,868 shares (SEC Form 4)

Director Harmon Cyrus sold $204,841 worth of shares (25,000 units at $8.19), decreasing direct ownership by 3% to 744,140 units (SEC Form 4)

SEC Form 4 filed by See Explanation of Responses Bvf Partners L P/Il

SEC Form 4 filed by Director Larson Yi

SEC Form 4 filed by Director Hrustanovic Gorjan

SEC Form 4 filed by Director Clark Ian T

SEC Form 4 filed by Director Horning Sandra

SEC Form 4 filed by Director Garland J. Scott

SEC Form 4 filed by Director Butitta Cynthia M

SEC Form 4 filed by Director Harmon Cyrus

SEC Form 4 filed by Director Rappaport Andrew

SEC Form 4 filed by Director Graham G. Walmsley

Amendment: SEC Form 4 filed by Director Graham G. Walmsley

SEC Form 4 filed by CH. DISCOV. & NON-CLIN DEV OFF Myles David C.

SEC Form 4 filed by CHIEF MEDICAL OFFICER Zojwalla Naseem

SEC Form 4 filed by CHIEF LEGAL OFFICER Mitchell Shawnte

SEC Form 4 filed by CH. OPERATING & FINANCIAL OFF. Kovacs Shane William Charles

SEC Form 4 filed by PRESIDENT AND CEO Bohen Sean

See Explanation of Responses Bvf Partners L P/Il returned 420,000 shares to the company (SEC Form 4)

CHIEF MEDICAL OFFICER Zojwalla Naseem exercised 14,000 shares at a strike of $4.87, increasing direct ownership by 12% to 129,509 units (SEC Form 4)

Director Harmon Cyrus was granted 29,250 shares and sold $147,956 worth of shares (16,393 units at $9.03), increasing direct ownership by 2% to 764,140 units (SEC Form 4)

CH. DISCOV. & NON-CLIN DEV OFF Myles David C. was granted 48,750 shares and sold $234,916 worth of shares (26,066 units at $9.01), increasing direct ownership by 4% to 598,333 units (SEC Form 4)

CHIEF MEDICAL OFFICER Zojwalla Naseem was granted 52,000 shares and sold $250,456 worth of shares (27,805 units at $9.01), increasing direct ownership by 26% to 115,509 units (SEC Form 4)

CH. OPERATING & FINANCIAL OFF. Kovacs Shane William Charles sold $316,703 worth of shares (35,159 units at $9.01) and was granted 68,250 shares, increasing direct ownership by 6% to 543,549 units (SEC Form 4)

PRESIDENT AND CEO Bohen Sean was granted 204,750 shares and sold $986,365 worth of shares (109,502 units at $9.01), increasing direct ownership by 65% to 241,662 units (SEC Form 4)

See Explanation of Responses Bvf Partners L P/Il returned 3,369,704 shares to the company (SEC Form 4)

Amendment: Director Graham G. Walmsley sold $17,448,750 worth of shares (1,175,000 units at $14.85) (SEC Form 4)

Ch. Operating & Financial Off. Kovacs Shane William Charles exercised 25,000 shares at a strike of $7.02, increasing direct ownership by 5% to 510,458 units (SEC Form 4)

Large owner Paradigm Biocapital Advisors Lp sold $35,796,000 worth of shares (2,400,000 units at $14.91) (SEC Form 4)

Director Harmon Cyrus sold $77,872 worth of shares (5,000 units at $15.57), decreasing direct ownership by 0.66% to 751,283 units (SEC Form 4)

Director Harmon Cyrus sold $61,300 worth of shares (5,000 units at $12.26), decreasing direct ownership by 0.66% to 756,283 units (SEC Form 4)

Director Harmon Cyrus sold $215,400 worth of shares (20,000 units at $10.77), decreasing direct ownership by 3% to 761,283 units (SEC Form 4)

SEC Form 4 filed by Director Bvf Partners L P/Il

SEC Form 4 filed by Director Rappaport Andrew

SEC Form 4 filed by Director Garland J. Scott

SEC Form 4 filed by Director Larson Yi

SEC Form 4 filed by Director Hrustanovic Gorjan

SEC Form 4 filed by Director Clark Ian T

SEC Form 4 filed by Director Harmon Cyrus

SEC Form 4 filed by Director Horning Sandra

SEC Form 4 filed by Director Graham G. Walmsley

SEC Form 4 filed by Director Butitta Cynthia M